Clearmind verwelkomt Trumps besluit als stimulans voor psychedelica en veteranenzorg

Clearmind Medicine has responded positively to an executive order signed by President Trump, describing it as a significant step forward for psychedelic-based medical research. The company sees the order as potentially opening doors for innovation in treatments involving psychedelic substances. Clearmind also highlights possible benefits for veteran mental health care as part of this policy shift.